5Indexed trials
drug · Product Intelligence
Levodopa
Pipeline Intelligence
Levodopa: 5 indexed trials, 5 sponsors; 0 linked Orange Book patents and 10 FDA-linked events where matched.
5Sponsors
0Orange Book patent links
10FDA-linked events
Development evidence
NCT00004733National Institute of Neurological Disorders and Stroke (NINDS) · parkinsonsPHASE3
NCT00102284University Hospital Muenster · other_neurologyPHASE4
NCT00812760Medical University of Vienna · out_of_scopePHASE4
NCT00845000Merck Sharp & Dohme LLC · parkinsonsPHASE1
NCT05901350Qilu Hospital of Shandong University · parkinsonsNA
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALCARBIDOPA, LEVODOPA AND ENTACAPONE · 2025-04-15
FDA_APPROVALCARBIDOPA, LEVODOPA AND ENTACAPONE · 2022-01-25
FDA_APPROVALCARBIDOPA AND LEVODOPA · 2013-02-08
FDA_APPROVALCARBIDOPA, LEVODOPA AND ENTACAPONE · 2012-11-20
FDA_APPROVALCARBIDOPA AND LEVODOPA · 2004-06-16
FDA_APPROVALCARBIDOPA AND LEVODOPA · 2004-05-14
FDA_APPROVALCARBIDOPA AND LEVODOPA · 1995-06-29
FDA_APPROVALCARBIDOPA AND LEVODOPA · 1992-08-28
FDA_APPROVALCARBIDOPA AND LEVODOPA · 1992-08-28
FDA_APPROVALCARBIDOPA AND LEVODOPA · 1992-08-28
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.